In vitro identification of targeting ligands of human M cells by phage display

International Journal of Pharmaceutics

Volumn 394, Issue 1-2, 2010, Pages 35-42

  Fievez, V ^a   Plapied, L ^a   Plaideau, C ^a   Legendre, D ^a   des Rieux, A ^a   Pourcelle, V ^a   Freichels, H ^b   Jerome C ^b   Marchand, J ^a   Preat V ^a   Schneider, Y J ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Caco 2 cells; M cells; Nanoparticles; Oral delivery; Phage display; Targeting

Indexed keywords

CYSTEINYLTHREONYLGLYCYLLYSYLSERYLCYSTEINE PEPTIDE; LEUCYLARGININYLVALYLGLYCINE PEPTIDE; LIGAND; NANOPARTICLE; PROLYLALANYLVALYLLEUCYLGLYCINE PEPTIDE; UNCLASSIFIED DRUG; PEPTIDE; PEPTIDE LIBRARY; POLYMER; VACCINE;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL STRAIN CACO 2; CELL SURFACE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CELL; LIGAND BINDING; MOLECULAR LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; SEQUENCE ANALYSIS; TRANSCYTOSIS; CACO 2 CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; ENTEROBACTERIA PHAGE T7; EPITHELIUM CELL; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION; PEPTIDE LIBRARY; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, ORAL; BACTERIOPHAGE T7; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; LIGANDS; NANOPARTICLES; PEPTIDE LIBRARY; PEPTIDES; POLYMERS; SEQUENCE ANALYSIS, PROTEIN; VACCINES;

EID: 77953724746     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.04.023     Document Type: Article

References (40)

1. Artursson P. Epithelial transport of drugs in cell culture. I. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 1990, 79:476-482.
2. Brayden D.J., Jepson M.A., Baird A.W. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov. Today 2005, 10:1145-1157.
3. Danner S., Belasco J.G. T7 phage display: a novel genetic selection system for cloning RNA-binding proteins from cDNA libraries. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12954-12959.
4. des Rieux A., Fievez V., Garinot M., Schneider Y.J., Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 2006, 116:1-27.
5. des Rieux A., Fievez V., Theate I., Mast J., Preat V., Schneider Y.J. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur. J. Pharm. Sci. 2007, 30:380-391.
6. des Rieux A., Ragnarsson E., Gullberg E., Préat V., Schneider Y.J., Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur. J. Pharm. Sci. 2005, 25:455-465.
7. Ermak T.H., Giannasca P.J. Microparticle targeting to M cells. Adv. Drug Deliv. Rev. 1998, 34:261-283.
8. Essler M., Ruoslahti E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2252-2257.
9. Fievez V., Plapied L., des Rieux A., Pourcelle V., Freichels H., Wascotte V., Vanderhaeghen M.L., Jérôme C., Vanderplasschen A., Marchand-Brynaert J., Schneider Y.J., Préat V. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur. J. Pharm. Biopharm. 2009, 73:16-24.
10. Florence A.T. Nanoparticle uptake by the oral route: fulfilling its potential?. Drug Discov. Today: Technol. 2005, 2:75-81.
11. Garinot M., Fievez V., Pourcelle V., Stoffelbach F., des Rieux A., Plapied L., Theate I., Freichels H., Jérôme C., Marchand-Brynaert J., Schneider Y.J., Préat V. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J. Control. Release 2007, 120:195-204.
12. Gebert A., Rothkotter H.J., Pabst R. M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 1996, 167:91-159.
13. Gullberg E., Keita A.V., Salim S.Y., Andersson M., Caldwell K.D., Soderholm J.D., Artursson P. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J. Pharmacol. Exp. Ther. 2006, 319:632-639.
14. Gullberg E., Leonard M., Karlsson J., Hopkins A.M., Brayden D., Baird A.W., Artursson P. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem. Biophys. Res. Commun. 2000, 279:808-813.
15. Gullberg, E, Velin Keita, A., Salim, S.Y., Andersson, M., Caldwell, K., Söderholm, J.D., Artursson P., 2005. Increased CD9 and B1-integrin expression in human follicule associated epithelium is linked with selective transport into human Peyer's patches. Particle Transcytosis Across the Human Intestinal Epithelium (Thesis).
16. Hase K., Kawano K., Nochi T., Pontes G.S., Fukuda S., Ebisawa M., Kadokura K., Tobe T., Fujimura Y., Kawano S., Yabashi A., Waguri S., Nakato G., Kimura S., Murakami T., Iimura M., Hamura K., Fukuoka S., Lowe A.W., Itoh K., Kiyono H., Ohno H. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009, 462:226-230.
17. Herrmann S., Leshem B., Lobel L., Bin H., Mendelson E., Ben-Nathan D., Dussart P., Porgador A., Rager-Zisman B., Marks R.S. T7 phage display of Ep15 peptide for the detection of WNV IgG. J. Virol. Methods 2007, 141:133-140.
18. Higgins L.M., Lambkin I., Donnelly G., Byrne D., Wilson C., Dee J., Smith M., O'Mahony D.J. In vivo phage display to identify M cell-targeting ligands. Pharm. Res. 2004, 21:695-705.
19. Ivanenkov V.V., Felici F., Menon A.G. Corrigendum to: 'Uptake and intracellular fate of phage display vectors in mammalian cells'. Biochim. Biophys. Acta 1999, 1451:364.
20. Ivanenkov V.V., Felici F., Menon A.G. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim. Biophys. Acta 1999, 448:463-472.
21. Ivanenkov V.V., Menon A.G. Peptide-mediated transcytosis of phage display vectors in MDCK cells. Biochem. Biophys. Res. Commun. 2000, 276:251-257.
22. Jain S., Vyas S.P. Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol. 2005, 57:1177-1184.
23. Jain S., Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J. Liposome Res. 2006, 16:331-345.
24. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 2000, 50:147-160.
25. Kang S.K., Woo J.H., Kim M.K., Woo S.S., Choi J.H., Lee H.G., Lee N.K., Choi Y.J. Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells. J. Biotechnol. 2008, 135:210-216.
26. Katz D.E., DeLorimier A.J., Wolf M.K., Hall E.R., Cassels F.J., van Hamont J.E., Newcomer R.L., Davachi M.A., Taylor D.N., McQueen C.E. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 2003, 21:341-346.
27. Kim S.H., Lee K.Y., Kim J., Park S.M., Park B.K., Jang Y.S. Identification of a peptide enhancing mucosal and systemic immune responses against EGFP after oral administration in mice. Mol. Cells 2006, 21:244-250.
28. Kuolee R., Chen W. M cell-targeted delivery of vaccines and therapeutics. Expert Opin. Drug Deliv. 2008, 5:693-702.
29. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157:105-132.
30. Lavelle E.C., O'Hagan D.T. Delivery systems and adjuvants for oral vaccines. Expert Opin. Drug Deliv. 2006, 3:747-762.
31. Pourcelle V., Freichels H., Stoffelbach F., Auzely-Velty R., Jérôme C., Marchand-Brynaert J. Light induced functionalization of PCL-PEG block copolymers for the covalent immobilization of biomolecules. Biomacromolecules 2009, 10:966-974.
32. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001, 2:361-367.
33. Shakweh M., Besnard M., Nicolas V., Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice. Eur. J. Pharm. Biopharm. 2005, 61:1-13.
34. Sharma N., Oikonomopoulou K., Ito K., Renaux B., Diamandis E.P., Hollenberg M.D., Rancourt D.E. Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display. Biol. Chem. 2008, 389:1097-1105.
35. Silin D.S., Lyubomska O.V., Jirathitikal V., Bourinbaiar A.S. Oral vaccination: where we are?. Expert Opin. Drug Deliv. 2007, 4:323-340.
36. Slutter B., Plapied L., Fievez V., Alonso-Sande M., des Rieux A., Schneider Y.J., Van Riet E., Jiskoot W., Préat V. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J. Control. Release 2009, 138:113-121.
37. Smith G.P., Petrenko V.A. Phage display. Chem. Rev. 1997, 97:391-410.
38. Tacket C.O., Reid R.H., Boedeker E.C., Losonsky G., Nataro J.P., Bhagat H., Edelman R. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine 1994, 12:1270-1274.
39. Takagi T., Arisawa T., Yamamoto K., Hirata I., Nakano H., Sawada M. Identification of ligands binding specifically to inflammatory intestinal mucosa using phage display. Clin. Exp. Pharmacol. Physiol. 2007, 34:286-289.
40. Woiwode T.F., Haggerty J.E., Katz R., Gallop M.A., Barrett R.W., Dower W.J., Cwirla S.E. Synthetic compound libraries displayed on the surface of encoded bacteriophage. Chem. Biol. 2003, 10:847-858.